Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Biomed Research International|September 9, 2014
Variability in myosteatosis and insulin resistance induced by high-fat diet in mouse skeletal musclesMassimo Collino, Raffaella Mastrocola, Debora Nigro, et al.
Life Sciences|May 22, 2003
Pro-oxidant effect of dehydroepiandrosterone in rats is mediated by PPAR activationRaffaella Mastrocola, Manuela Aragno, Silvia Betteto, et al.
International Journal of Oncology|July 10, 2003
Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexiaMaria G Catalano, Nicoletta Fortunati, Katia Arena, et al.
Diabetes Care|August 21, 2007
Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patientsEnrico Brignardello, Cristina Runzo, Manuela Aragno, et al.
British Journal of Pharmacology|March 18, 2010
Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammationMassimo Collino, Manuela Aragno, Sara Castiglia, et al.
Free Radical Biology & Medicine|November 5, 2010
Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic ratsMassimo Collino, Elisa Benetti, Gianluca Miglio, et al.
Biochemical Pharmacology|October 30, 2012
Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-δ agonism correlates with impaired NLRP3 inflammasome activationMassimo Collino, Elisa Benetti, Mara Rogazzo, et al.
Mediators of Inflammation|July 18, 2013
High sugar intake and development of skeletal muscle insulin resistance and inflammation in mice: a protective role for PPAR- δ agonismElisa Benetti, Raffaella Mastrocola, Mara Rogazzo, et al.
Endocrinology|September 17, 2005
Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatmentManuela Aragno, Raffaella Mastrocola, Claudio Medana, et al.
The Journal of Endocrinology|November 8, 2006
Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cellsMaria G Catalano, Nicoletta Fortunati, Mariateresa Pugliese, et al.
Pageof 8